M1396 – Patients on a therapeutic clinical trial

Long description

Patients on a therapeutic clinical trial

Short description

Pt ther clin trial

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2025

Last change

January 1, 2025 – No change

Nearby M codes

• M1387 – Patients who died during the performance period
• M1388 – Patients with documentation of an exam performed for recurrence of melanoma
• M1390 – Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period
• M1391 – All patients who were diagnosed with recurrent melanoma during the current performance period
• M1392 – Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)
• M1393 – Patients who were not diagnosed with recurrent melanoma during the current performance period
• M1394 – Stages i-iii breast cancer
• M1395 – Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group
• M1397 – Patients with recurrence/disease progression
• M1398 – Patients with baseline and follow-up promis surveys documented in the medical record
• M1399 – Patients who leave the practice during the follow-up period
• M1400 – Patients who died during the follow-up period
• M1401 – Stages i-iii breast cancer
• M1402 – Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group
• M1403 – Patients with baseline and follow-up promis surveys documented in the medical record
• M1404 – Patients on a therapeutic clinical trial